Boardroom Alpha
Boardroom Alpha
ACTG · Current Report (Form 8-K) · Filed June 25, 2026

Acacia Research Corp — Current Report (Form 8-K)

Form
8-K
Filed
June 25, 2026
Period
Jun 23, 2026
Ticker
ACTG
Accession
0000934549-26-000029
Boardroom Alpha · Filing insights

Stockholders elected seven directors, ratified Grant Thornton LLP as auditor, and approved executive compensation.

About Acacia Research Corp
Market cap
$436M
1Y TSR
+36.8%
3Y TSR
+6.3%
Board grade
B-
Sector
Industrials
CEO
Martin D McNulty Jr
Last annual meeting: Jun 23, 2026 · View full Acacia Research Corp profile →
actg-20260623

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): June 23, 2026
ACACIA RESEARCH CORPORATION
(Exact name of registrant as specified in its charter)
Delaware001-3772195-4405754
(State or other jurisdiction of
incorporation)
(Commission
File Number)
(I.R.S. Employer
Identification No.)
767 Third Avenue,
6th Floor
New York,
NY10017
(Address of principal executive offices)(Zip Code)
(Registrant’s telephone number, including area code): (949) 480-8300
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
oWritten communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
oSoliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
oPre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
oPre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading SymbolName of each exchange on which registered
Common Stock, par value $0.001 per shareACTGThe Nasdaq Stock Market, LLC
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).      Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.



Item 5.07.
Submission of Matters to a Vote of Security Holders.

On June 23, 2026, Acacia Research Corporation (the “Company”) held its 2026 Annual Meeting of Stockholders (the “Annual Meeting”) virtually via live webcast at www.virtualshareholdermeeting.com/ACTG2026. As of April 28, 2026, the record date for the Annual Meeting, there were 96,589,132 shares of the Company’s common stock (the “Common Stock”), issued, outstanding and entitled to vote.

At the Annual Meeting, 86,674,540 shares of the Common Stock were present virtually or represented by proxy, constituting a quorum for the conduct of business at the Annual Meeting.

Set forth below are brief descriptions of the proposals voted upon at the Annual Meeting, and the final results of the stockholder vote on each proposal, as certified by Broadridge Financial Solutions Inspector of Election Services, the inspector of election for the Annual Meeting. These proposals are described in more detail in the Company’s definitive proxy statement, filed with the Securities and Exchange Commission on May 1, 2026.

Proposal No. 1: To elect seven directors to serve on the Company’s Board of Directors until the 2027 Annual Meeting of Stockholders or until their respective successors are duly elected and qualified.

DirectorsForAgainstAbstainBroker
Non-Votes
Gavin Molinelli77,547,5593,657,97162,2955,406,715
Michelle Felman77,089,2534,114,03464,5385,406,715
Isaac T. Kohlberg77,410,2763,795,15362,3965,406,715
Martin D. McNulty, Jr.77,617,1623,588,25762,4065,406,715
Maureen O’Connell77,451,6961,334,6972,481,4325,406,715

Proposal No. 2: To ratify the appointment of Grant Thornton, LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026.

Votes ForVotes AgainstVotes AbstainingBroker Non-Votes
85,775,969839,30459,267

Proposal No. 3: To approve, on a non-binding, advisory basis, the compensation of the Company’s named executive officers.

Votes ForVotes AgainstVotes AbstainingBroker Non-Votes
79,726,9781,064,903475,9445,406,715





SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: June 25, 2026
ACACIA RESEARCH CORPORATION
By:/s/ Jason Soncini
Name:Jason Soncini
Title:General Counsel

From this filing to the file

Every SEC filing, parsed structured.

Boardroom Alpha indexes every 8-K, 10-K, 10-Q, and proxy back to 2000 — vote tabulations, comp tables, red flags, insider transactions, all queryable the day they hit EDGAR.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Acacia Research Corp (ACTG)

Reference

Frequently asked questions

When did Acacia Research Corp file this 8-K?
Acacia Research Corp (ACTG) filed this Current Report (Form 8-K) with the SEC on June 25, 2026. The accession number assigned by EDGAR is 0000934549-26-000029.
What does an 8-K disclose?
Form 8-K is the SEC's current-report form, used to disclose material events between periodic reports (10-K / 10-Q). Triggers include CEO/CFO departures, acquisitions, bankruptcies, earnings releases, auditor changes, changes in fiscal year, and amendments to corporate governance. Each 8-K is keyed to one or more Item numbers (1.01 through 9.01).
What is the key takeaway from this filing?
Stockholders elected seven directors, ratified Grant Thornton LLP as auditor, and approved executive compensation. This is Boardroom Alpha's one-line summary of the current report; see the full filing text above for the formal disclosure.
What Item codes does an 8-K cover?
An 8-K's Item codes (1.01 through 9.01) specify what kind of event is being disclosed — e.g. Item 1.01 for entering a material agreement, Item 5.02 for departure/election of directors and executive officers, Item 8.01 for other events. The Item codes for this 8-K appear in the filing text above.
Where can I find Acacia Research Corp's prior current reports on EDGAR?
The SEC EDGAR browser lists every 8-K Acacia Research Corp has filed under CIK 934549, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer